Search filters

List of works by Cora Sternberg

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016.

scientific article published on 8 December 2016

A consensus definition of patients with metastatic urothelial carcinoma who are unfit for cisplatin-based chemotherapy

scientific article published on 01 March 2011

A nomogram including baseline prognostic factors to estimate the activity of second-line therapy for advanced urothelial carcinoma

scientific article

A randomised phase II trial of three dosing regimens of radium-223 in patients with bone metastatic castration-resistant prostate cancer

scientific article published on 23 December 2019

A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: final overall survival results and safety update.

scientific article

A randomized, double-blind, placebo-controlled phase II study of maintenance therapy with tasquinimod in patients with metastatic castration-resistant prostate cancer responsive to or stabilized during first-line docetaxel chemotherapy.

scientific article published on 20 October 2017

A systematic review of neoadjuvant and adjuvant chemotherapy for muscle-invasive bladder cancer

scientific article published on June 2012

A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer

scientific article

Abiraterone acetate for patients with metastatic castration-resistant prostate cancer progressing after chemotherapy: final analysis of a multicentre, open-label, early-access protocol trial

scientific article published on 18 September 2014

Abiraterone acetate for treatment of metastatic castration-resistant prostate cancer: final overall survival analysis of the COU-AA-301 randomised, double-blind, placebo-controlled phase 3 study ⬇️

scientific article published on September 18, 2012

Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3

scientific article published on 16 January 2015

Abiraterone and increased survival in metastatic prostate cancer

scientific article (publication date: 26 May 2011)

Accelerating precision medicine in metastatic prostate cancer

scientific article published on 17 November 2020

Adapting treatment for prostate cancer according to risk of disease progression

scientific article published on 26 August 2008

Adjuvant Chemotherapy for Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis of Individual Participant Data from Randomised Controlled Trials

scientific article published in 2022

Adjuvant Vascular Endothelial Growth Factor-targeted Therapy in Renal Cell Carcinoma: A Systematic Review and Pooled Analysis

scientific article published on 18 May 2018

Adjuvant leuprolide with or without docetaxel in patients with high-risk prostate cancer after radical prostatectomy (TAX-3501): important lessons for future trials

scientific article

Advances in the treatment of urothelial tract tumors

scientific article

Algorithms in the First-Line Treatment of Metastatic Clear Cell Renal Cell Carcinoma--Analysis Using Diagnostic Nodes

scientific article published on 3 August 2015

Amplification of epidermal growth factor receptor gene in renal cell carcinoma

article

An open-label extension study to evaluate safety and efficacy of pazopanib in patients with advanced renal cell carcinoma

scientific article published on 06 September 2014

An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors

scientific article

Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risks

scientific article

Assessing the impact of evolving evidence in renal cell carcinoma treatment: an update of the Renal Cell Carcinoma Appropriateness-based Treatment Toolkit (ReCATT).

scientific article

Assessment of the Safety of Glucocorticoid Regimens in Combination With Abiraterone Acetate: A Randomized, Open-Label Phase 2 Study

scientific article published on 27 June 2019

Association Between New Unconfirmed Bone Lesions and Outcomes in Men With Metastatic Castration-Resistant Prostate Cancer Treated With Enzalutamide: Secondary Analysis of the PREVAIL and AFFIRM Randomized Clinical Trials

scientific article published on 12 December 2019

Association of Survival Benefit With Docetaxel in Prostate Cancer and Total Number of Cycles Administered: A Post Hoc Analysis of the Mainsail Study.

scientific article published in January 2017

Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab

scientific article published on 09 April 2019

Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma

scientific article published on 18 September 2020

Bacillus Calmette-Guerin in the treatment of stage T1 grade 3 transitional cell carcinoma of the bladder: long-term results

scientific article published on 01 December 1995

Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults

scientific article published on January 2010

Bladder cancer

scientific article published on 01 January 2002

Bladder cancer today

scientific article published on 01 November 2008

Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancer.

scientific article

CDK12-Altered Prostate Cancer: Clinical Features and Therapeutic Outcomes to Standard Systemic Therapies, Poly (ADP-Ribose) Polymerase Inhibitors, and PD-1 Inhibitors

scientific article published on 21 April 2020

COMPARZ Post Hoc Analysis: Characterizing Pazopanib Responders With Advanced Renal Cell Carcinoma

scientific article published on 06 February 2019

Cabazitaxel versus Abiraterone or Enzalutamide in Metastatic Prostate Cancer

scientific article published on 30 September 2019

Cabozantinib versus everolimus in advanced renal cell carcinoma (METEOR): final results from a randomised, open-label, phase 3 trial.

scientific article

Can patient selection for bladder preservation be based on response to chemotherapy?

scientific article published on 18 March 2003

Carboplatin and 5-fluorouracil in poor performance status patients with advanced urothelial cancer

scientific article

Castration-resistant prostate cancer: current and emerging treatment strategies

scientific article published on May 2010

Castration-resistant prostate cancer: from new pathophysiology to new treatment targets.

scientific article published on 24 June 2009

Chemotherapeutic management of invasive bladder carcinoma

scientific article published on 01 January 1988

Chemotherapy and management of bladder tumours.

scientific article

Chemotherapy for Muscle-Invasive Bladder Cancer.

scientific article

Chemotherapy for advanced urothelial tract tumors: the M-VAC regimen

scientific article published on 01 January 1988

Chemotherapy for bladder cancer: treatment guidelines for neoadjuvant chemotherapy, bladder preservation, adjuvant chemotherapy, and metastatic cancer.

scientific article published on January 2007

Chemotherapy of urologic malignancies

scientific article

Chemotherapy with an every-2-week regimen of gemcitabine and paclitaxel in patients with transitional cell carcinoma who have received prior cisplatin-based therapy.

scientific article

Circulating Tumor Cells in a Phase 3 Study of Docetaxel and Prednisone with or without Lenalidomide in Metastatic Castration-resistant Prostate Cancer

scientific article published on 10 August 2016

Clinical and pharmacokinetic evaluation of satraplatin ⬇️

scientific article published on November 19, 2011

Clinical outcomes in patients receiving three lines of targeted therapy for metastatic renal cell carcinoma: results from a large patient cohort

scientific article published on 18 March 2013

Clinical presentation, pathological features and natural course of metastatic uveal melanoma, an orphan and commonly fatal disease

scientific article published on 23 April 2014

Clonal evolution of chemotherapy-resistant urothelial carcinoma.

scientific article published on 17 October 2016

Colorectal cancer and antiangiogenic therapy: what can be expected in clinical practice?

scientific article

Common germline-somatic variant interactions in advanced urothelial cancer

scientific article published on 03 December 2020

Comparing comparators: a look at control arms in kidney cancer studies over the years.

scientific article published on 6 November 2014

Concurrent or layered treatment with radium-223 and enzalutamide or abiraterone/prednisone: real-world clinical outcomes in patients with metastatic castration-resistant prostate cancer

scientific article published on 13 May 2020

Contemporary Role of Androgen Deprivation Therapy for Prostate Cancer ⬇️

scientific article published on August 19, 2011

Contemporary management of metastatic castration-resistant prostate cancer

scientific article published on May 2011

Continuous infusion gallium nitrate for patients with advanced refractory urothelial tract tumors

scientific article published on 01 December 1991

Critical analysis of bladder sparing with trimodal therapy in muscle-invasive bladder cancer: a systematic review.

scientific article published on 26 February 2014

Current Clinical Practice Guidelines for the Treatment of Renal Cell Carcinoma: A Systematic Review and Critical Evaluation

scientific article published on 07 June 2017

Current and emerging treatment modalities for metastatic castration‐resistant prostate cancer ⬇️

scientific article published on 01 April 2011

Current indications for chemotherapy in prostate cancer patients.

scientific article published on 22 August 2006

Current status of chemotherapy for urothelial tract tumors.

scientific article published on July 1987

Current therapies and advances in the treatment of pancreatic cancer

scientific article

Design and end points of clinical trials for patients with progressive prostate cancer and castrate levels of testosterone: recommendations of the Prostate Cancer Clinical Trials Working Group

scientific article

Development and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients with Advanced Renal Cell Carcinoma Treated with Pazopanib

scientific article published on 17 June 2015

Development and validation of a prognostic model for overall survival in chemotherapy-naïve men with metastatic castration-resistant prostate cancer

scientific article published on 01 November 2018

Differences in gene expression in muscle-invasive bladder cancer: a comparison of Italian and American patients.

scientific article published in April 2001

Docetaxel and prednisone with or without lenalidomide in chemotherapy-naive patients with metastatic castration-resistant prostate cancer (MAINSAIL): a randomised, double-blind, placebo-controlled phase 3 trial

scientific article published on 3 March 2015

Docetaxel plus oblimersen sodium (Bcl-2 antisense oligonucleotide): an EORTC multicenter, randomized phase II study in patients with castration-resistant prostate cancer.

scientific article

Dose Escalation and Pharmacokinetics Study of Enzastaurin and Sunitinib Versus Placebo and Sunitinib in Patients With Metastatic Renal Cell Carcinoma ⬇️

scientific article published on 01 October 2012

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.

scientific article published on 17 February 2014

ESMO / ASCO Recommendations for a Global Curriculum in Medical Oncology Edition 2016

scientific article (publication date: 2016)

Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis

scientific article published on 12 July 2019

Effect of Visceral Disease Site on Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer Treated With Enzalutamide in the PREVAIL Trial.

scientific article

Effect of abiraterone acetate and prednisone compared with placebo and prednisone on pain control and skeletal-related events in patients with metastatic castration-resistant prostate cancer: exploratory analysis of data from the COU-AA-301 randomis

scientific article published on November 9, 2012

Effect of abiraterone acetate on fatigue in patients with metastatic castration-resistant prostate cancer after docetaxel chemotherapy ⬇️

scientific article published on November 14, 2012

Effect of abiraterone acetate treatment on the quality of life of patients with metastatic castration-resistant prostate cancer after failure of docetaxel chemotherapy

scientific article published on 22 August 2013

Effect of enzalutamide on health-related quality of life, pain, and skeletal-related events in asymptomatic and minimally symptomatic, chemotherapy-naive patients with metastatic castration-resistant prostate cancer (PREVAIL): results from a randomi

scientific article published on 14 April 2015

Effect of enzalutamide on time to first skeletal-related event, pain, and quality of life in men with castration-resistant prostate cancer: results from the randomised, phase 3 AFFIRM trial

scientific article published on 4 August 2014

Effective chemotherapy for hormone-refractory prostate cancer (HRPC): present status and perspectives with taxane-based treatments

scientific article published on 30 October 2006

Efficacy and safety of enzalutamide in patients 75 years or older with chemotherapy-naive metastatic castration-resistant prostate cancer: results from PREVAIL.

scientific article

Efficacy of Surgery in the Primary Tumor Site for Metastatic Urothelial Cancer: Analysis of an International, Multicenter, Multidisciplinary Database

scientific article published on 13 July 2019

Efficacy of tivozanib treatment after sorafenib in patients with advanced renal cell carcinoma: crossover of a phase 3 study.

scientific article published on 13 March 2018

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

scientific article published on 29 May 2020

Enzalutamide for the treatment of metastatic castration-resistant prostate cancer

scientific article

Enzalutamide in Castration-Resistant Prostate Cancer

scientific article published on 01 October 2018

Enzalutamide in European and North American men participating in the AFFIRM trial

scientific article published on 23 October 2014

Enzalutamide in Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer: Extended Analysis of the Phase 3 PREVAIL Study

scientific article published on 28 July 2016

Enzalutamide in Men with Nonmetastatic, Castration-Resistant Prostate Cancer

scientific article published on 01 June 2018

Enzalutamide in metastatic prostate cancer before chemotherapy

scientific article published in June 2014

Escalated M-VAC chemotherapy and recombinant human granulocyte-macrophage colony stimulating factor (rhGM-CSF) in patients with advanced urothelial tract tumors

scientific article

Etoposide (VP-16) in the treatment of advanced adenocarcinoma of the pancreas

scientific article published on 01 April 1988

Evaluation of new anticancer agents against human pancreatic carcinomas in nude mice

scientific article

Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodology

scientific article published on 14 March 2012

Everything old is new again! Neoadjuvant chemotherapy in the treatment of muscle-invasive bladder cancer.

scientific article

External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study.

scientific article published on 7 October 2010

Future directions and targeted therapies in bladder cancer

scientific article published on 13 December 2014

Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma.

scientific article published in June 2009

Gemcitabine, paclitaxel, pemetrexed and other newer agents in urothelial and kidney cancers

scientific article

Health-Related Quality-of-Life Analysis From KEYNOTE-045: A Phase III Study of Pembrolizumab Versus Chemotherapy for Previously Treated Advanced Urothelial Cancer.

scientific article published on 28 March 2018

High grade superficial (G3t1) transitional cell carcinoma of the bladder treated with intravesical Bacillus Calmette-Guerin (BCG)

scientific article published on 01 December 2003

High-risk metastatic urothelial cancer: chances for cure?

scientific article

Hormonal therapy and chemotherapy in hormone-naive and castration resistant prostate cancer

scientific article

ICUD-EAU International Consultation on Bladder Cancer 2012: Chemotherapy for urothelial carcinoma-neoadjuvant and adjuvant settings.

scientific article published on 14 August 2012

ICUD-EAU International Consultation on Kidney Cancer 2010: treatment of metastatic disease

scientific article published on 24 June 2011

IL8 polymorphisms and overall survival in pazopanib- or sunitinib-treated patients with renal cell carcinoma

scientific article

Immediate versus deferred chemotherapy after radical cystectomy in patients with pT3-pT4 or N+ M0 urothelial carcinoma of the bladder (EORTC 30994): an intergroup, open-label, randomised phase 3 trial

scientific article

Immune-checkpoint inhibitors and metastatic prostate cancer therapy: Learning by making mistakes

scientific article published on 10 June 2020

Impact of COVID-19 pandemic on treatment patterns in metastatic clear cell renal cell carcinoma

scientific article published on 01 July 2020

Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: A Retrospective International Study of Invasive/advanced cancer of the urothelium (RISC).

scientific article published on 25 October 2017

Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)

scientific article published on 01 November 2019

Impact of primary tumor location on survival from EORTC advanced urothelial cancer studies.

scientific article published on 17 November 2017

Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival

scientific article published on 10 July 2020

Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial

scientific article published on 01 February 2014

In Reply

article published in 2008

Incidence, Patterns, and Outcomes with Adjuvant Chemotherapy for Residual Disease After Neoadjuvant Chemotherapy in Muscle-invasive Urinary Tract Cancers

scientific article published on 30 January 2019

Increased survival with enzalutamide in prostate cancer after chemotherapy

scientific article (publication date: 27 September 2012)

Incremental Utility of Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer: Quantifying the Relapse Risk Associated with Therapeutic Effect

scientific article published on 11 July 2019

Inhibition of the VEGF/VEGFR pathway improves survival in advanced kidney cancer: a systematic review and meta-analysis

scientific article

Integrating cytokines and angiogenic factors and tumour bulk with selected clinical criteria improves determination of prognosis in advanced renal cell carcinoma

scientific article published on 6 July 2017

Integration of whole-exome and anchored PCR-based next generation sequencing significantly increases detection of actionable alterations in precision oncology

scientific article published on 12 November 2020

Is there a role for presurgical therapy for renal cell carcinoma?

scientific article published on June 2010

Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis

scientific article

Larotaxel with Cisplatin in the first-line treatment of locally advanced/metastatic urothelial tract or bladder cancer: a randomized, active-controlled, phase III trial (CILAB).

scientific article published on 24 September 2013

Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale

scientific article published on 28 January 2019

Lobaplatin in advanced urothelial tract tumors. The Genitourinary Group of the European Organization for Research and Treatment of Cancer (EORTC).

scientific article

Localized and locally advanced bladder cancer.

scientific article

Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guérin: 18-year experience

scientific article published on 01 February 2002

Long-term results with immediate androgen suppression and external irradiation in patients with locally advanced prostate cancer (an EORTC study): a phase III randomised trial

scientific article

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium

scientific article

M-VAC: methotrexate (MTX), vinblastine (VLB), adriamycin (ADM), and cisplatin (DDP) for metastatic and node positive carcinoma of the urothelium

scientific article

MIFA III (mitomycin-C, 5-fluorouracil, and adriamycin) chemotherapy for advanced adenocarcinoma of the pancreas

scientific article published on 01 October 1984

Management of Patients with Advanced Prostate Cancer: Report of the Advanced Prostate Cancer Consensus Conference 2019

scientific article published on 27 January 2020

Management of Patients with Advanced Prostate Cancer: The Report of the Advanced Prostate Cancer Consensus Conference APCCC 2017.

scientific article

Management of advanced prostate cancer after first-line chemotherapy

scientific article

Management of good risk germ-cell tumours

scientific article

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015

scientific article published on 02 May 2016

Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015.

scientific article published on 3 June 2015

Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology

scientific article published on 25 March 2010

Many men with castrate-sensitive metastatic prostate cancer should not receive chemotherapy.

scientific article published on 12 December 2015

Metastatic bladder cancer: anything new?

scientific article published on September 2012

Metastatic chromophobe renal cell carcinoma treated with targeted therapies: A Renal Cross Channel Group study ⬇️

scientific article published on 23 May 2017

Metastatic renal cell carcinoma: recent advances in the targeted therapy era.

scientific article published on 08 September 2009

Methotrexate, vinblastine, doxorubicin, and cisplatin for advanced transitional cell carcinoma of the urothelium. Efficacy and patterns of response and relapse

scientific article published in December 1989

Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials

scientific article published on 07 September 2018

Multicenter trial of the quantitative BTA TRAK assay in the detection of bladder cancer

scientific article published on 01 April 1999

Multidisciplinary management of bone complications in prostate cancer and optimizing outcomes of bisphosphonate therapy

scientific article published on February 2007

Multinational, double-blind, phase III study of prednisone and either satraplatin or placebo in patients with castrate-refractory prostate cancer progressing after prior chemotherapy: the SPARC trial

scientific article

Muscle-invasive transitional cell carcinoma of the bladder: strategies for bladder preservation

scientific article published on 01 September 1998

Neo-adjuvant M-VAC chemotherapy trials in transitional cell carcinoma: perspectives for first line chemotherapy

scientific article published on January 1988

Neo-adjuvant chemotherapy and bladder preservation in locally advanced transitional cell carcinoma of the bladder

scientific article published in November 1999

Neoadjuvant Chemotherapy for Invasive Bladder Cancer ⬇️

scientific article published on April 1, 2012

Neoadjuvant M-VAC (methotrexate, vinblastine, adriamycin, and cisplatin) chemotherapy and bladder preservation for muscle-infiltrating transitional cell carcinoma of the bladder

scientific article published in May 1995

Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.

scientific article

Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors

scientific article published on 01 March 1988

Neoadjuvant and adjuvant chemotherapy in advanced disease--what are the effects on survival and prognosis?

scientific article published on June 1995

Neoadjuvant and adjuvant chemotherapy in locally advanced bladder cancer

scientific article published on 01 September 1997

Neoadjuvant and adjuvant chemotherapy in muscle-invasive bladder cancer

scientific article published on 16 October 2008

Neoadjuvant m-vac (methotrexate, vinblastine, doxorubicin, and cisplatin) for infiltrating transitional cell carcinoma of the bladder

scientific article published on 15 September 1993

Neoadjuvant systemic therapy for urological malignancies

scientific article published on July 2010

Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database

New drugs and new approaches for the treatment of metastatic urothelial cancer

scientific article

New therapies for castration-resistant prostate cancer: efficacy and safety

scientific article published on 04 May 2011

Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).

scientific article

Novel Agents and Approaches for Advanced Renal Cell Carcinoma ⬇️

scientific article published on July 19, 2012

Novel Molecular Targets for the Therapy of Castration-Resistant Prostate Cancer ⬇️

scientific article published on December 22, 2011

Novel agents for muscle-invasive and advanced urothelial cancer

scientific article

Novel targeted therapy for advanced renal carcinoma: trials in progress

scientific article published on September 2010

Once-daily dasatinib: expansion of phase II study evaluating safety and efficacy of dasatinib in patients with metastatic castration-resistant prostate cancer

scientific article

Open-label phase II study evaluating the efficacy and safety of two doses of pertuzumab in castrate chemotherapy-naive patients with hormone-refractory prostate cancer.

scientific article

Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel.

scientific article published on 03 April 2014

Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach

scientific article published on 23 August 2008

Overall Survival Endpoint in Oncology Clinical Trials: Addressing the Effect of Crossover--The Case of Pazopanib in Advanced Renal Cell Carcinoma.

scientific article

PD38-02 AVELUMAB FIRST-LINE MAINTENANCE FOR ADVANCED UROTHELIAL CARCINOMA: LONG-TERM OUTCOMES FROM JAVELIN BLADDER 100 IN SUBGROUPS DEFINED BY FIRST-LINE CHEMOTHERAPY REGIMEN AND ANALYSIS OF OVERALL SURVIVAL FROM START OF FIRST-LINE CHEMOTHERAPY ⬇️

scholarly article

Partial Response and Stable Disease Correlate with Positive Outcomes in Atezolizumab-treated Patients with Advanced Urinary Tract Carcinoma

scientific article published on 06 November 2020

Patient-reported outcomes following enzalutamide or placebo in men with non-metastatic, castration-resistant prostate cancer (PROSPER): a multicentre, randomised, double-blind, phase 3 trial

scientific article published on 12 February 2019

Pazopanib Exposure Relationship with Clinical Efficacy and Safety in the Adjuvant Treatment of Advanced Renal Cell Carcinoma.

scientific article published on 12 January 2018

Pazopanib efficacy in renal cell carcinoma: evidence for predictive genetic markers in angiogenesis-related and exposure-related genes.

scientific article

Pazopanib for the treatment of renal cell carcinoma and other malignancies.

scientific article published on September 2009

Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial

scientific article (publication date: 20 February 2010)

Pazopanib versus sunitinib in metastatic renal-cell carcinoma

scientific article

Pazopanib, a potent orally administered small-molecule multitargeted tyrosine kinase inhibitor for renal cell carcinoma

scientific article published on February 2008

Pazopanib: Clinical development of a potent anti-angiogenic drug

scientific article published on 24 April 2010

Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.

scientific article published on 17 February 2017

Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica

scientific article published on 21 March 2018

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma

scientific article

Phase 3 Assessment of the Automated Bone Scan Index as a Prognostic Imaging Biomarker of Overall Survival in Men With Metastatic Castration-Resistant Prostate Cancer: A Secondary Analysis of a Randomized Clinical Trial

Phase I/II trial of intravesical methotrexate for superficial bladder tumors

scientific article published on 01 January 1986

Phase II EORTC trial with 5-fluorouracil, cisplatin and interferon-alpha as second-line treatment of advanced transitional cell cancer of the urothelial tract

scientific article published on 01 November 2000

Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti-angiogenic treatment.

scientific article published in January 2012

Phase II evaluation of m-AMSA (4'-(9-acridinylamino)-methanesulfon-m-anisidide) in patients with adenocarcinoma of the pancreas

scientific article published on 01 August 1983

Phase II evaluation of metoprine in advanced pancreatic adenocarcinoma

scientific article published on 01 July 1984

Phase II study of dasatinib in patients with metastatic castration-resistant prostate cancer

scientific article

Phase II trial of N-methylformamide for advanced renal cell carcinoma

scientific article published on 01 May 1986

Phase II trial of elliptinium in advanced renal cell carcinoma and carcinoma of the breast

scientific article

Phase II trial of idarubicin in patients with pancreatic cancer

scientific article published on 01 June 1987

Phase II trial of menogarol in the treatment of advanced adenocarcinoma of the pancreas

scientific article published on 01 April 1988

Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology Program

scientific article published on 01 April 1989

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.

scientific article

Phase III trial of satraplatin, an oral platinum plus prednisone vs. prednisone alone in patients with hormone-refractory prostate cancer

scientific article published on 28 February 2005

Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis

scientific article published on 24 September 2019

Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)

scientific article published on 19 October 2012

Precision, complexity and stigma in advanced prostate cancer terminology: it is time to move away from 'castration-resistant' prostate cancer

scientific article published in August 2017

Preliminary results of M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for transitional cell carcinoma of the urothelium

article by C N Sternberg et al published 1 March 1985 in Journal of Urology

Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract

scientific article published on 23 March 2019

Prognostic Association of Prostate-specific Antigen Decline with Clinical Outcomes in Men with Metastatic Castration-resistant Prostate Cancer Treated with Enzalutamide in a Randomized Clinical Trial

scientific article published on 03 December 2018

Prognostic factors for survival of patients with advanced urothelial tumors treated with methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy

scientific article published on 01 March 1991

Prognostic factors in patients receiving third line targeted therapy for metastatic renal cell carcinoma.

scientific article published on 26 November 2014

Prognostic impact of transurethral resection on patients irradiated for localized prostate cancer

scientific article published on 01 May 1995

Prognostic model predicting metastatic castration-resistant prostate cancer survival in men treated with second-line chemotherapy

scientific article published on 17 October 2013

Prognostic or predictive plasma cytokines and angiogenic factors for patients treated with pazopanib for metastatic renal-cell cancer: a retrospective analysis of phase 2 and phase 3 trials

scientific article

Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy

scientific article published on 6 January 2015

Progress in the treatment of advanced prostate cancer

scientific article published on January 2014

Progression after docetaxel-based chemotherapy in androgen-independent prostate cancer

scientific article published on 08 June 2007

Prostate Cancer Unit Initiative in Europe: A position paper by the European School of Oncology.

scientific article published on 05 June 2015

Prostate-specific Antigen Progression in Enzalutamide-treated Men with Nonmetastatic Castration-resistant Prostate Cancer: Any Rise in Prostate-specific Antigen May Require Closer Monitoring

scientific article published on 30 September 2020

Prostate-specific antigen flare phenomenon with docetaxel-based chemotherapy in patients with androgen-independent prostate cancer

scientific article

Quality of life in patients with metastatic prostate cancer following treatment with cabazitaxel versus abiraterone or enzalutamide (CARD): an analysis of a randomised, multicentre, open-label, phase 4 study

scientific article published on 11 September 2020

Radiographic Progression-Free Survival as a Clinically Meaningful End Point in Metastatic Castration-Resistant Prostate Cancer: The PREVAIL Randomized Clinical Trial

scientific article published on 8 March 2018

Radiographic progression with nonrising PSA in metastatic castration-resistant prostate cancer: post hoc analysis of PREVAIL.

scientific article

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial

scientific article

Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial

scientific article published on 18 November 2019

Randomized Phase III Trial of Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma.

scientific article published on 13 September 2017

Randomized phase II study of danusertib in patients with metastatic castration-resistant prostate cancer after docetaxel failure

scientific article published on 29 August 2012

Randomized phase III KEYNOTE-045 trial of pembrolizumab versus paclitaxel, docetaxel, or vinflunine in recurrent advanced urothelial cancer: results of >2 years of follow-up

scientific article published on 01 June 2019

Randomized phase III trial of high-dose-intensity methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) chemotherapy and recombinant human granulocyte colony-stimulating factor versus classic MVAC in advanced urothelial tract tumors: European

scientific article published on 01 May 2001

Randomized, Double-Blind, Placebo-Controlled Phase III Study of Tasquinimod in Men With Metastatic Castration-Resistant Prostate Cancer

scientific article published on 13 June 2016

Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study

scientific article

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

article

Recent advances in the treatment of advanced renal cell carcinoma: towards multidisciplinary personalized care

scientific article published on 30 March 2012

Recombinant tumor necrosis factor for superficial bladder tumors

scientific article published on 01 November 1992

Reducing the burden of bone metastases: current concepts and treatment options

scientific article published on 07 March 2013

Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye

scientific article published on 10 November 2014

Reply to S. Barni et Al and M. Sun et Al

scientific article published on 29 September 2014

Results from a Phase I Study of Lapatinib with Gemcitabine and Cisplatin in Advanced or Metastatic Bladder Cancer: EORTC Trial 30061.

scientific article published on 16 October 2015

Results of bard bta test in monitoring patients with a history of transitional cell cancer of the bladder

scientific article published in May 1997

Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study.

scientific article

Role of targeted therapy in the treatment of advanced prostate cancer

scientific article published on March 2010

Role of the novel generation of androgen receptor pathway targeted agents in the management of castration-resistant prostate cancer: A literature based meta-analysis of randomized trials

scientific article

Rucaparib in Men With Metastatic Castration-Resistant Prostate Cancer Harboring a BRCA1 or BRCA2 Gene Alteration

scientific article published on 14 August 2020

SIU-ICUD recommendations on bladder cancer: systemic therapy for metastatic bladder cancer

scientific article published on 20 September 2018

Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

article

Safety and efficacy of atezolizumab in patients with autoimmune disease: Subgroup analysis of the SAUL study in locally advanced/metastatic urinary tract carcinoma

scientific article published on 06 September 2020

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme

scientific article published on 23 July 2018

Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: final results from an expanded-access trial.

scientific article

Safety and tolerability of pazopanib in the treatment of renal cell carcinoma ⬇️

scientific article published on August 4, 2012

Satraplatin for the therapy of castration-resistant prostate cancer

scientific article published on September 2009

Second-line systemic therapy and emerging drugs for metastatic transitional-cell carcinoma of the urothelium

scientific article published on 25 May 2010

Second-line treatment for metastatic clear cell renal cell cancer: experts' consensus algorithms

scientific article published on 3 August 2016

Sequelae of treatment in long-term survivors of testis cancer

scientific article published on 12 June 2011

Sequencing of agents for metastatic renal cell carcinoma: can we customize therapy?

scientific article published on 30 October 2011

Sequential targeted therapy after pazopanib therapy in patients with metastatic renal cell cancer: efficacy and toxicity

scientific article published on 14 March 2014

Sequential use of targeted agents in the treatment of renal cell carcinoma

scientific article published on 11 August 2010

Seven year update of an EORTC phase III trial of high-dose intensity M-VAC chemotherapy and G-CSF versus classic M-VAC in advanced urothelial tract tumours.

scientific article published on 5 December 2005

Signal-transduction inhibitors in renal cell carcinoma

scientific article published on May 2007

Six-month progression-free survival as the primary endpoint to evaluate the activity of new agents as second-line therapy for advanced urothelial carcinoma

scientific article published on 28 September 2013

State-of-the-art management of metastatic disease at initial presentation or recurrence

scientific article published on November 2006

Suggestions for regulatory agency approval of second-line systemic therapy for metastatic transitional cell carcinoma

scientific article published on 16 February 2010

Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma

scientific article published on 18 July 2014

Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors

scientific article published on 4 December 2014

Targeted therapies for renal cell carcinoma: review of adverse event management strategies

scientific article published on 10 January 2012

The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer

scientific article published on 01 April 2019

The Impact of Enzalutamide on the Prostate Cancer Patient Experience: A Summary Review of Health-Related Quality of Life across Pivotal Clinical Trials ⬇️

journal article from 'Cancers' published in 2021

The Natural History and Outcome Predictors of Metastatic Castration-resistant Prostate Cancer.

scientific article

The PREVAIL Study: Primary Outcomes by Site and Extent of Baseline Disease for Enzalutamide-treated Men with Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer

scientific article published on 19 March 2016

The application of hematopoietic growth factors in advanced transitional cell carcinoma of the urinary tract

scientific article

The contemporary role of chemotherapy for advanced testis cancer: a systematic review of the literature.

scientific article published on 24 March 2012

The evolving role of chemotherapy in advanced urothelial cancer

scientific article published on October 2007

The medical management of prostate cancer: a multidisciplinary team approach.

scientific article published on 6 September 2006

The requirements of a specialist Prostate Cancer Unit: a discussion paper from the European School of Oncology

scientific article published in December 2010

The role of abiraterone acetate in the management of prostate cancer: a critical analysis of the literature.

scientific article

The role of bisphosphonates or denosumab in light of the availability of new therapies for prostate cancer

scientific article published on 03 May 2018

The role of docetaxel based therapy for prostate cancer in the era of targeted medicine

scientific article published on 19 January 2010

Thoughts on a systematic review and meta-analysis of adjuvant chemotherapy in muscle-invasive bladder cancer

scientific article published on 23 January 2014

Time from prior chemotherapy enhances prognostic risk grouping in the second-line setting of advanced urothelial carcinoma: a retrospective analysis of pooled, prospective phase 2 trials

scientific article

Tivozanib versus sorafenib as initial targeted therapy for patients with metastatic renal cell carcinoma: results from a phase III trial

scientific article published on 09 September 2013

Toxicities following treatment with bisphosphonates and receptor activator of nuclear factor-κB ligand inhibitors in patients with advanced prostate cancer

scientific article published on 13 May 2013

Toxicities of targeted therapy and their management in kidney cancer.

scientific article published on 14 January 2011

Transurethral resection of the prostate and metastatic prostate cancer

scientific article published in November 1991

Treatment Patterns and Outcomes in Patients With Metastatic Castration-resistant Prostate Cancer in a Real-world Clinical Practice Setting in the United States

scientific article published on 07 January 2020

Treatment of brain metastases from bladder cancer

scientific article published in March 1993

Treatment of metastatic urothelial cancer: opportunities for drug discovery and development

scientific article

Treatment of patients with metastatic urothelial cancer "unfit" for Cisplatin-based chemotherapy.

scientific article published on 09 May 2011

Treatment options in hormone resistant prostate cancer.

scientific article

Treatment patterns and characteristics of European patients with castration-resistant prostate cancer

scientific article

Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3

scientific article

Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab

scientific article published on 28 April 2022

Update on Systemic Prostate Cancer Therapies: Management of Metastatic Castration-resistant Prostate Cancer in the Era of Precision Oncology

scientific article published on 16 April 2018

Upper tract urothelial carcinoma topical issue 2016: treatment of metastatic cancer.

scientific article published on 24 June 2016

Vinflunine in platinum-pretreated patients with locally advanced or metastatic urothelial carcinoma: results of a large phase 2 study

scientific article published on September 2009

What has been learned from meta-analyses of neoadjuvant and adjuvant chemotherapy in bladder cancer?

scientific article published on 01 September 2006

What's new in the treatment of metastatic kidney cancer?

scientific article

Which traits affect how long patients with advanced prostate cancer live when treated with enzalutamide?

scientific article published in 2022

Paulina is supported by:

About Paulina

Help